Azifudine is a class 1 anti-AIDS drug targeting RNA reverse transcriptase. It has good anti-novel coronavirus activity at the cellular and animal levels against COVID-19

Kymera Has announced the results of a trial of kTX-201, a protein inhibitor targeting STAT3 proteins. The results showed that KTX-201 can change the characteristics of tumor microenvironment in a mouse solid tumor model, making tumors more sensitive to PD-1 inhibitors, thus enhancing the effect of P......

If you are looking for a supplier or manufacturer of 7-Bromo-1,1,1-trifluoroheptan-2-one (CAS No.: 647831-24-1) please contact us.

Tetrachromobisphenol A is the largest flame retardant in the world, mainly (90%) is a reactive brominated flame retardant covalently bound to the polymer structure, which is released compared to the additive flame retardant. The possibility of the environment is smaller.

Despite the continuous improvement of technologies such as target validation, high-throughput screening, computationally-aided drug design, toxicity prediction, druggability optimization, patient selection, and clinical trial design, the success rate of clinical drug development has remained at 10-1......

Jnana Therapeutics announced that it has selected JNT-517 as a development candidate and potential "first-in-class" oral approach for the treatment of phenylketonuria (PKU). This is a rare genetic metabolic disease. The company plans to launch a Phase 1 clinical trial evaluating JNT-517 later this y......